In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $15.78 in the prior trading day, Immunovant Inc (NASDAQ: IMVT) closed at $14.58, down -7.60%. In other words, the price has decreased by -$7.60 from its previous closing price. On the day, 3.87 million shares were traded. IMVT stock price reached its highest trading level at $15.67 during the session, while it also had its lowest trading level at $14.16.
Ratios:
Our goal is to gain a better understanding of IMVT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.04 and its Current Ratio is at 6.04. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 03, 2025, initiated with a Hold rating and assigned the stock a target price of $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 07 ’25 when Fromkin Andrew J. sold 8,000 shares for $19.60 per share. The transaction valued at 156,769 led to the insider holds 91,913 shares of the business.
ANDREW J FROMKIN bought 8,000 shares of IMVT for $156,160 on Mar 07 ’25. On Feb 19 ’25, another insider, Macias William L., who serves as the Chief Medical Officer of the company, sold 2,055 shares for $20.86 each. As a result, the insider received 42,867 and left with 357,353 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 2476573184 and an Enterprise Value of 2101906816.
Stock Price History:
The Beta on a monthly basis for IMVT is 0.76, which has changed by -0.52228045 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, IMVT has reached a high of $34.47, while it has fallen to a 52-week low of $14.90. The 50-Day Moving Average of the stock is -25.83%, while the 200-Day Moving Average is calculated to be -44.29%.
Shares Statistics:
The stock has traded on average 1.60M shares per day over the past 3-months and 2364730 shares per day over the last 10 days, according to various share statistics. A total of 147.20M shares are outstanding, with a floating share count of 69.37M. Insiders hold about 59.16% of the company’s shares, while institutions hold 49.43% stake in the company. Shares short for IMVT as of 1741910400 were 15799702 with a Short Ratio of 9.86, compared to 1739491200 on 14788106. Therefore, it implies a Short% of Shares Outstanding of 15799702 and a Short% of Float of 18.059998999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
